Chinese (SSE) Drug Retail Industry Analysis

UpdatedDec 15, 2025

DataAggregated Company Financials

Companies9

7D-5.1%
3M-6.6%
1Y-8.5%
YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 5.1%, driven by pullbacks from every company within the industry. However, the industry is down 8.5% over the past year. As for the next few years, earnings are expected to grow by 20% per annum.

Industry Valuation and Performance

Has the Chinese Drug Retail Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Tue, 16 Dec 2025	CN¥85.1b	CN¥121.2b	CN¥3.6b	27.7x	23.6x	0.7x
Thu, 13 Nov 2025	CN¥95.1b	CN¥121.2b	CN¥3.6b	31.5x	26.4x	0.8x
Sat, 11 Oct 2025	CN¥87.6b	CN¥120.6b	CN¥3.3b	30.4x	26.3x	0.7x
Mon, 08 Sep 2025	CN¥90.9b	CN¥120.7b	CN¥3.3b	29.7x	27.6x	0.8x
Wed, 06 Aug 2025	CN¥93.6b	CN¥120.4b	CN¥3.3b	31.6x	28.7x	0.8x
Fri, 04 Jul 2025	CN¥93.6b	CN¥120.4b	CN¥3.3b	31.8x	28.7x	0.8x
Sun, 01 Jun 2025	CN¥94.8b	CN¥120.4b	CN¥3.3b	32.1x	29.1x	0.8x
Tue, 29 Apr 2025	CN¥92.6b	CN¥121.0b	CN¥3.9b	22x	23.5x	0.8x
Thu, 27 Mar 2025	CN¥88.6b	CN¥121.0b	CN¥3.9b	20.6x	22.7x	0.7x
Sat, 22 Feb 2025	CN¥86.6b	CN¥121.0b	CN¥3.9b	20x	22.2x	0.7x
Mon, 20 Jan 2025	CN¥80.6b	CN¥121.0b	CN¥3.9b	18.4x	20.6x	0.7x
Wed, 18 Dec 2024	CN¥92.4b	CN¥121.0b	CN¥3.9b	21x	23.7x	0.8x
Fri, 15 Nov 2024	CN¥92.4b	CN¥121.0b	CN¥3.9b	20.8x	23.7x	0.8x
Sun, 13 Oct 2024	CN¥82.4b	CN¥119.6b	CN¥4.3b	18.7x	19.1x	0.7x
Tue, 10 Sep 2024	CN¥76.8b	CN¥119.6b	CN¥4.3b	21.8x	17.9x	0.6x
Thu, 08 Aug 2024	CN¥77.0b	CN¥118.4b	CN¥4.8b	18x	16.1x	0.7x
Sat, 06 Jul 2024	CN¥84.2b	CN¥118.4b	CN¥4.8b	19.8x	17.6x	0.7x
Mon, 03 Jun 2024	CN¥121.7b	CN¥118.4b	CN¥4.8b	25.5x	25.4x	1x
Wed, 01 May 2024	CN¥122.3b	CN¥117.1b	CN¥4.8b	26.1x	25.6x	1x
Fri, 29 Mar 2024	CN¥113.1b	CN¥115.1b	CN¥5.3b	20.8x	21.5x	1x
Sun, 25 Feb 2024	CN¥118.1b	CN¥115.9b	CN¥5.8b	21.6x	20.3x	1x
Tue, 23 Jan 2024	CN¥118.6b	CN¥116.0b	CN¥5.7b	21x	20.7x	1x
Thu, 21 Dec 2023	CN¥123.9b	CN¥116.0b	CN¥5.7b	22.1x	21.6x	1.1x
Sat, 18 Nov 2023	CN¥127.5b	CN¥115.4b	CN¥5.7b	22.7x	22.4x	1.1x
Mon, 16 Oct 2023	CN¥116.4b	CN¥113.6b	CN¥5.7b	22.3x	20.5x	1x
Wed, 13 Sep 2023	CN¥121.8b	CN¥113.6b	CN¥5.7b	23.8x	21.5x	1.1x
Fri, 11 Aug 2023	CN¥131.8b	CN¥109.7b	CN¥5.4b	28.2x	24.2x	1.2x
Sun, 09 Jul 2023	CN¥127.8b	CN¥109.7b	CN¥5.4b	27x	23.5x	1.2x
Tue, 06 Jun 2023	CN¥132.1b	CN¥109.7b	CN¥5.4b	26.9x	24.3x	1.2x
Thu, 04 May 2023	CN¥134.8b	CN¥104.6b	CN¥5.0b	28.4x	26.8x	1.3x
Sat, 01 Apr 2023	CN¥142.9b	CN¥91.6b	CN¥4.2b	34.7x	34x	1.6x
Mon, 27 Feb 2023	CN¥144.2b	CN¥90.3b	CN¥4.0b	35.4x	35.8x	1.6x
Wed, 25 Jan 2023	CN¥144.2b	CN¥90.3b	CN¥4.0b	37x	35.8x	1.6x
Fri, 23 Dec 2022	CN¥138.3b	CN¥90.3b	CN¥4.0b	35.2x	34.4x	1.5x

Price to Earnings Ratio

34.4x

Fri, 23 Dec 2022

Current Industry PE

Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.

The industry is trading close to its 3-year average PE ratio of 24.5x.

The industry is trading close to its 3-year average PS ratio of 0.97x.

Past Earnings Growth

The earnings for companies in the Drug Retail industry have declined 3.7% per year over the last three years.
Meanwhile revenues for these companies have grown 10% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.